Streetbeat News

Equity Actions

ACRS

ALEC

INVO

LIFW

MYNZ

TCBP

TCON

TENX

TIVC

TNON

VERV

ZVSA

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Tenax Therapeutics (TENX) saw a massive increase of 319.0% to $0.65 with an exceptionally high trading volume. Tivic Health Systems (TIVC) rose by 68.89% following their Q3 earnings release. ZyVersa Therapeutics (ZVSA), INVO Bioscience (INVO), MSP Recovery (LIFW), and Tenon Medical (TNON) also saw gains ranging from 18.27% to 32.88%. On the downside, TC BioPharm (TCBP) plummeted by 90.0%, Aclaris Therapeutics (ACRS) dropped by 86.77%, and other stocks like Mainz Biomed (MYNZ), Verve Therapeutics (VERV), TRACON Pharma (TCON), and Alector (ALEC) experienced declines between 16.58% and 45.54%.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 5:31 pm

WDAY

Workday's (NYSE:WDAY) short interest has decreased by 3.93% since the last report, with 3.53 million shares sold short, representing 1.71% of available shares. The average time to cover these short positions is 2.8 days. A decrease in short interest can indicate a more bullish sentiment towards the stock, although it does not guarantee a price rise. Workday has less short interest compared to its peer group average of 3.37%.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 5:30 pm

AUVI

Applied UV shares are trading lower following the announcement of a $6.4 million upsized underwritten public offering.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 5:20 pm

AUVI

Applied UV Inc (NASDAQ:AUVI) stock plummeted by 43% to $0.15 after the company announced the pricing of its public offering at $0.15 per unit, aiming to raise $6.4 million in gross proceeds. The offering was increased from $6.0 million and includes options for Aegis Capital Corp. to buy additional shares and warrants. The funds are intended for repaying notes and general corporate purposes, with the offering expected to close on November 16.

Portfolio Pulse from Henry Khederian

November 14, 2023 | 5:18 pm

KBNT

Kubient Inc (NASDAQ:KBNT) stock plummeted nearly 52% to $0.10 after the company announced its voluntary delisting from the Nasdaq Capital Market due to noncompliance with listing requirements. The Board of Directors decided to delist to avoid the costs and regulatory burdens of addressing noncompliance notices. Trading on Nasdaq will cease on November 17, with delisting about ten days later. Kubient plans to have its stock quoted on the Pink Sheets or another OTC Markets Group Inc. market, but trading continuity is uncertain.

Portfolio Pulse from Henry Khederian

November 14, 2023 | 5:07 pm

BLK

John Liu commented on the impact of BlackRock's cryptocurrency ETF filing, suggesting it paves the way for other institutions to file for similar ETFs, potentially increasing institutional involvement in the cryptocurrency market.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 4:40 pm

GME

IBKR

At the Benzinga Fintech Deal Day & Awards, industry experts discussed shifts in investor behavior post-Covid, with a focus on retail engagement and technology. Stocktwits CEO Rishi Khanna noted a decline in market entry pace and a move past the memestock craze. eToro's U.S. CEO Lule Demmissie highlighted technology and access as growth drivers, with a focus on fixed income and AI innovation. UpLeg's Abdul Zoheb emphasized educational content and trading technology. Interactive Brokers' Steve Sanders reported an uptick in accounts during volatility and a recent surge in bond interest.

Portfolio Pulse from Surbhi Jain

November 14, 2023 | 4:17 pm

BNPQY

NMR

Fnality, a blockchain-based wholesale payments firm, raised $95.09 million in its second funding round, led by Goldman Sachs Group Inc. (GS) and BNP Paribas (BNPQY). Other participants included DTCC, Euroclear, Nomura Holdings Inc (NMR), and WisdomTree. The firm, which was founded in 2019 as a UBS-led blockchain project, is awaiting the Bank of England's approval to start operations. The funding will help establish a global liquidity management network for digital payment models in wholesale financial markets and tokenized asset markets, aiming to bridge the gap between mainstream and digital finance.

Portfolio Pulse from Khyathi Dalal

November 14, 2023 | 4:05 pm

CPRT

The analysis of Copart (NASDAQ:CPRT) in the Commercial Services & Supplies industry reveals that it has high PE, PB, and PS ratios compared to peers, suggesting a premium valuation. Despite a low ROE and revenue growth, Copart's EBITDA and gross profit are robust. The company's low debt-to-equity ratio indicates a strong financial position with less reliance on debt. Overall, Copart may be overvalued relative to its industry peers.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 4:00 pm

BIIB

The article provides an industry comparison of Biogen (NASDAQ:BIIB) against its competitors in the Biotechnology industry, focusing on financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, revenue growth, and debt-to-equity ratio. Biogen appears undervalued based on P/E, P/B, and P/S ratios compared to industry averages, but shows potential inefficiencies with a negative ROE, lower EBITDA, gross profit, and revenue growth. The company's lower debt-to-equity ratio suggests a stronger financial position relative to its top 4 peers.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 4:00 pm